SRT-100 Vision featured on San Antonio News
SRT-100 Vision a New Technology Revolutionizing Skin Cancer Treatment Skin cancer—it’s the most common cancer in the United States. An estimated one in five Americans will develop skin cancer in their lifetimes, but there’s a new technology that’s revolutionizing how patients are treated and it’s in the San Antonio area. “I’ve had skin cancers now […]
Superficial radiation therapy offers an effective alternative to Mohs surgery
Dr. David Goldberg spoke at the 2017 South Beach Symposium conference on how SRT technology has rapidly advanced in the past 30 years and how SRT is an effective way to eradicate tumors while maintaining or improving patients’ quality of life. Below is an excerpt from the article by Healio.com covering this presentation: MIAMI — Superficial […]
Superficial radiation therapy provides safe, aesthetic results for non-melanoma skin cancer patients
MIAMI — At South Beach Symposium 2017, symposium chairman Mark S. Nestor, MD, PhD, discusses the efficacy and cosmetic benefits of superficial radiation therapy to treat both non-melanoma skin cancer and recurring keloid scars. Nestor presented at the symposium on innovative breakthroughs in superficial radiation therapy, including new technology from Sensus Healthcare. To watch the […]
Sensus Healthcare to Participate in 2017 South Beach Symposium on February 9 – 12 in Miami
— Joe Sardano, Sensus Healthcare CEO, to Participate in CEO Forum on February 11 — Sensus Healthcare Medical Advisory Board Members to Host SRT Workshops on February 9 BOCA RATON, Fla., Feb. 7, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin […]
Sensus Healthcare Reports Fourth Quarter and Full Year 2016 Results
– Record Quarterly Revenues of $4.9 million in Fourth Quarter – Full Year 2016 revenues increased 44% year-over-year to $14.8 million – Worldwide installed base increased to 271 units BOCA RATON, Fla., Feb. 2, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other […]
